Merck agrees $1 billion deal with Debiopharm for head and neck cancer drug FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph OrlowskiBERLIN (Reuters) – [...]